Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021 6 0
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 5 1
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 6 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 7 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Excel (.xslx) CSV (.csv)